DME Capital Management’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
VCM
VPM
RCMNY
DME Capital Management's VTRS Position: Q1 2026 in Review
DME Capital Management opened a new position in Viatris (VTRS) in Q1 2026: 1,817,570 shares worth $24.6M. The stake represents 0.77% of the portfolio and ranks #34 among its holdings. This is a return to the name: DME Capital Management previously reported a position in VTRS as recently as Q1 2025.
DME Capital Management first reported a position in VTRS in Q1 2024 and has held it in 6 quarters since. The position peaked at $84.4M in Q3 2024. 1,019 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.
- DME Capital Management held 1,817,570 shares of Viatris worth $24.6M as of Q1 2026.
- Viatris was a new DME Capital Management position in Q1 2026.
- Viatris made up 0.77% of DME Capital Management's portfolio in Q1 2026, its #34 holding.
- DME Capital Management first reported a position in Viatris in Q1 2024 and has held it in 6 quarters since.
- DME Capital Management's Viatris position peaked at $84.4M in Q3 2024.
- 1,019 funds tracked by Wall St. Rank held Viatris as of Q1 2026.
Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.